Introduction {#Sec1}
============

Contrasting with the declining incidence of [*Mycobacterium tuberculosis*](https://doi.org/10.1601/nm.10886)-caused tuberculosis, the increasing number of nontuberculous mycobacteria infections is concerning. Amongst NTM, the [*Mycobacterium simiae*](https://doi.org/10.1601/nm.6402) complex contains 19 species \[[@CR1]\], including [*M. simiae*](https://doi.org/10.1601/nm.6402) \[[@CR2]\], which is considered the most important species in terms of its clinical relevance \[[@CR3]\]. [*M. simiae*](https://doi.org/10.1601/nm.6402) is a slow-growing saprophyte that has been isolated from several environments including water and soil \[[@CR3], [@CR4]\]. In addition to thriving in environmental niches, [*M. simiae*](https://doi.org/10.1601/nm.6402) has been associated to infections in both immunocompromised \[[@CR4], [@CR5]\] and immunocompetent patients \[[@CR6]\], with clinical cases reported worldwide \[[@CR5], [@CR6]\]. Thus, [*M. simiae*](https://doi.org/10.1601/nm.6402) is considered an emergent pathogen \[[@CR7]--[@CR9]\]. Previous sequencing efforts have provided draft genome sequences for [*M. simiae*](https://doi.org/10.1601/nm.6402), namely, strains MO323 (accession [PRJNA276839](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA276839)) and [DSM 44165](https://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+44165) (accession [PRJEB1560](https://www.ncbi.nlm.nih.gov/bioproject/PRJEB1560)) \[[@CR10]\], which were isolated in early years from the United States of America (1989) and India (1965), respectively. We expand here on this genomic data by reporting the genome sequence of a clinical isolate from a Mexican patient (bronchial lavage) obtained in 2011, designated as MsiGto, which is approximately 745 Kbp and 901 Kbp larger than the previously published [*M. simiae*](https://doi.org/10.1601/nm.6402) genomes, respectively. Additionally, we perform a comparative analysis between the genomes of strain MsiGto and the previously reported [DSM 44165](https://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+44165) and MO323 strains to provide insights that could unearth the transition from environmental bacteria to pathogenic NTM organisms.

Organism information {#Sec2}
====================

Classification and features {#Sec3}
---------------------------

To identify strain MsiGto as an [*M. simiae*](https://doi.org/10.1601/nm.6402) isolate, typical DNA markers for mycobacterial identification, such as the 16S rRNA, *rpoB* and *hsp65* genes \[[@CR11]--[@CR13]\] were localized on the sequenced MsiGto genome, and compared to other publicly available sequences using BLASTN on its default settings. The MsiGto 16S rRNA gene exhibited 100% identity with previously deposited [*M. simiae*](https://doi.org/10.1601/nm.6402) sequences (strains DS39, DS34, DS31, DS24, DS19, DS3, DS2, MO323 and [ATCC 25275](https://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DATCC+25275)). The MsiGto *rpoB* gene sequence showed 99% identity with [*M. simiae*](https://doi.org/10.1601/nm.6402) MO323. Similarly, there was 100% identity between the MsiGto and MO323 *hsp65* genes. For comparison, a BLAST of these markers from [DSM 44165](https://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+44165) and MO323 evidenced a similar trend with 99% identity for the 16S rRNA gene and 100% identity for *rpoB* and *hsp65*. Figure [1](#Fig1){ref-type="fig"} shows the phylogenetic position of [*M. simiae*](https://doi.org/10.1601/nm.6402) MsiGto within the [*M. simiae*](https://doi.org/10.1601/nm.6402) complex, based on a concatenated gene tree including the sequences of the 16S rRNA, *rpoB* and *hsp65* genes (1507 bp in total).Fig. 1Phylogenetic tree showing the relationship of [*M. simiae*](https://doi.org/10.1601/nm.6402) MsiGto with selected species members of the [*M. simiae*](https://doi.org/10.1601/nm.6402) Complex, including 2 relevant [*M. simiae*](https://doi.org/10.1601/nm.6402) strains. Phylogenetic reconstruction was obtained using Bayesian inference. Numbers at the nodes are the values of posterior probabilities. The tree was obtained after 1 million generations with mixed model. Sequence data from [*Mycobacterium tuberculosis*](https://doi.org/10.1601/nm.10886) H37Rv was used as an outgroup

Further analysis such as the Average Nucleotide Identity and Average Amino Acid Identity, preformed as previously reported \[[@CR14]\], confirmed the high resemblance between *M. simiae* MsiGto and *M simiae* strains MO323 and DSN 44165 (Table [1](#Tab1){ref-type="table"}). The ANI values were above 95% in all cases, indicating that the compared organisms belong to the same species. Similar results were found using Genome-to-Genome Distance Calculator \[[@CR15], [@CR16]\] with a calculated distance of 0.0292 and a DNA-DNA hybridization estimate of 77.40% using the formula for draft genomes. These results provide a taxonomic background in which the genome insights presented in the following sections can better accounted for, namely, large genotype differences of MsiGto, despite close taxonomic relationships with DSM 44165 and MO323 strains.Table 1Average Nucleotide Identity (A) and Average Amino acid Identity (B) between *M. simiae* MsiGto and other *M simiae* strains sequenced to dateOrganismM. simiae MsiGto A/BM. simiae DSM 44165M. simiae MO323M. simiae MsiGto--97.25/ 97.5198.99/98.95M. simiae DSM 4416597.25/ 97.51--97.26/97.59M. simiae MO32398.99/98.9597.26/97.59--

Genome sequencing information {#Sec4}
=============================

Genome project history {#Sec5}
----------------------

Despite [*M. simiae*](https://doi.org/10.1601/nm.6402) being one of the most relevant NTM due to its emergence as a human pathogen, the genomic features and genetic potential of this species remain poorly described. In collaboration with the State Laboratory of Public Health of Guanajuat, located in central Mexico, we had access to a clinical isolate of [*M. simiae*](https://doi.org/10.1601/nm.6402), termed MsiGto. The sample was isolated from a 90 years old female patient from León, the largest and most industrialized city of the State of Guanajuato, México, in 2011 (Table [2](#Tab2){ref-type="table"}). This sample was selected for genomic sequencing due to the emerging clinical importance of strains from the [*M. simiae*](https://doi.org/10.1601/nm.6402) complex worldwide \[[@CR8], [@CR9], [@CR17]--[@CR19]\], combined with a lack of representative genomic sequences from Mexico to this date. The available genome sequences could allow comparative analyses in order to increase our understanding of this opportunistic bacterium.Table 2Classification and general features of *Mycobacterium simiae* MsiGto \[[@CR51]\]MIGS IDPropertyTermEvidence code^a^ClassificationDomain *Bacteria*TAS \[[@CR52]\]Phylum *Actinobacteria*TAS \[[@CR53]\]Class *Actinobacteria*TAS \[[@CR54]\]Order *Actinomycetales*TAS \[[@CR55], [@CR56]\]Family *Mycobacteriaceae*\[[@CR54], [@CR56], [@CR57]\]Genus *Mycobacterium*TAS \[[@CR58], [@CR59]\]Species *Mycobacterium simiae*IDAGram stainWeakly PostiveIDACell shapeIrregular rodsIDAMotilityNon MotileIDASporulationNonsporulatingNASTemperature rangeMesophileNASOptimum temperature37 °CNASpH range; Optimum5.5--8; 7IDACarbon sourceStarchIDAMIGS-6HabitatHuman AssociatedNASMIGS-6.3SalinityNormalNASMIGS-22Oxygen requirementAerobicNASMIGS-15Biotic relationshipParasiticIDAMIGS-14PathogenicityPathogenicNASMIGS-4Geographic locationMexico/GuanajuatoNASMIGS-5Sample collection2014NASMIGS-4.1LatitudeNot ReportedNASMIGS-4.2LongitudeNot ReportedNASMIGS-4.4AltitudeNot ReportedNAS^a^Evidence codes - *IDA* Inferred from Direct Assay, *TAS* Traceable Author Statement (i.e., a direct report exists in the literature), *NAS* Non-traceable Author Statement (i.e., not directly observed for the living, isolated sample, but based on a generally accepted property for the species, or anecdotal evidence). These evidence codes are from the Gene Ontology project \[[@CR60]\]

Growth conditions and genomic DNA preparation {#Sec6}
---------------------------------------------

MsiGto was isolated from a sputum specimen. Briefly, 2 mL sample were transferred to a sterile tube and decontaminated by adding an equal volume of 4% NaOH with phenol red. The mix was immediately vortexed and incubated at 37 °C for 15 min. The liquefied sample was centrifuged at 3000 g at 4 °C for 15 min, the supernatant was discarded and pH was adjusted between the 6.5 and 7.2 range using 1 N HCL. Finally, 0.2 mL of sample were inoculated into Lowenstein-Jenssen slants (Difco) and incubated at 37 °C for three weeks.

Biomass was collected and suspended in phosphate buffered saline solution, pH 7.4, and inactivated by heating at 80 °C for 45 min. After centrifugation, genomic DNA was extracted from the pellet using the FastDNA SPIN Kit for Soil (MP Biomedicals) according to manufacturer's instructions. Extracted gDNA was assessed for quantity and quality using a NanoDrop Spectrophotometer (Thermo Fisher Scientific).

Genome sequencing and assembly {#Sec7}
------------------------------

The MsiGto genome was sequenced on a HiSeq 2000 platform with a 100 bp paired-end cycle according to standard Illumina protocols, at Macrogen facilities. Quality of the generated sequencing reads (13,676,836 reads, total read length: 1,381,360,436 bp) was checked with FastQC. Reads were filtered before assembly, such that both sequences in paired-end reads exhibited more than 90% bases of quality greater than or equal to Q20. Post-filtering Q20% was 97.69 and Q30% was 88.6 at the base level. The filtered reads were assembled using SOAP de novo aligner \[[@CR20]\], yielding 50 contigs. Scaffolding was performed with SSPACE Standard \[[@CR21]\] and resulted in 12 scaffolds, generating a genome size of 6.7 Mb with a coverage of 216X (Table [3](#Tab3){ref-type="table"}).Table 3Project informationMIGS IDPropertyTermMIGS 31Finishing qualityDraftMIGS-28Libraries usedPaired End IlluminaMIGS 29Sequencing platformsIllumina HiSeq 2000MIGS 31.2Fold coverage216MIGS 30AssemblersSOAPdenovoMIGS 32Gene calling methodRASTLocus TagB5M45Genbank ID[MZZM00000000](https://www.ncbi.nlm.nih.gov/nuccore/MZZM00000000)GenBank Date of ReleaseApril 17, 2017GOLD IDGa0183212BIOPROJECT[PRJNA378996](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA378996)MIGS 13Source Material Identifier*Mycobacterium simiae* MsiGtoProject relevanceMedical, Evolutionary

Genome annotation {#Sec8}
-----------------

Gene prediction and functional annotation were performed using the Rapid Annotation using Subsystem Technology platform \[[@CR22]\]. A prophage region prediction was completed using PHAST \[[@CR23]\]. CRISPRs were searched using the CRISPR finder, and antibiotic resistance genes were investigated using Resistance Gene Identifier from the Comprehensive Antibiotic Resistance Database \[[@CR24]\]. Genome-to-genome comparisons were performed using multiple approaches, including conservation analysis of protein families across genomes with the Protein Family Sorter from the PATRIC Platform \[[@CR25]\], and comparing functionally related clusters using the function-based comparison of the RAST server. MsiGto and related genomes were also aligned using a genome-wide BLAST comparison, and visualized through the Artemis Comparative Tool \[[@CR26]\] for manual inspection.

Genome properties {#Sec9}
=================

Genomic assembly yielded a total length of 6,684,413 bp fragmented in 50 contigs, the largest [*M. simiae*](https://doi.org/10.1601/nm.6402) genome reported to date. The MsiGto genome consists of a unique chromosome, as no plasmid DNA was found. The GC content of the genome was 66.08%, consistent with other reported [*M. simiae*](https://doi.org/10.1601/nm.6402) strains. Gene prediction analysis documented 3 rRNAs, 49 tRNAs and 6409 coding sequences. Out of these, 4462 genes (69.62%) were assigned to putative functions, and 3669 genes (approximately 62.57%) were assigned to clusters of orthologous groups functional categories. Sequence searches using RGI evidenced resistance genes to amynoglycosides, ethambutol and beta lactams, which is a concern as to date standard antibiotic regimes for this species include the use of ethambutol, the aminoglycoside amikacin, as well as the macrolides azithromycin and clarithromycin \[[@CR27]\]. The genome properties and statistics are summarized in Tables [4](#Tab4){ref-type="table"} and [5](#Tab5){ref-type="table"}. Gene distribution among the COG functional categories is shown in Table [6](#Tab6){ref-type="table"}. A circular map of MsiGto chromosome is provided in Fig. [2](#Fig2){ref-type="fig"}.Table 4Summary of genome: one chromosome, no plasmidsLabelSize (Mb)TopologyINSDC identifierRefSeq IDChromosome6,684,413CircularGenBank[NZ_MZZM00000000](https://www.ncbi.nlm.nih.gov/nuccore/NZ_MZZM00000000).1Table 5Genome statisticsAttributeValue% of TotalGenome size (bp)6,684,413100DNA coding (bp)5,978,00889.43DNA G + C (bp)4,416,39166.07DNA scaffolds15100Total genes6369100Protein coding genes629999.90RNA genes701.10Pseudo genes1602.51Genes in internal clusters5799.09Genes with function prediction471374.00Genes assigned to COGs527282.29Genes with Pfams domains500978.19Genes with signal peptides2604.08Genes with transmembrane helices129220.29CRISPR repeats15Table 6Number of genes associated with general COG functional categoriesCodeValue%age^a^DescriptionJ1612.53Translation, ribosomal structure and biogenesisA210.33RNA processing and modificationK4487.05TranscriptionL1923.02Replication, recombination and repairB10.01Chromatin structure and dynamicsD550.86Cell cycle control, Cell division, chromosome partitioningV470.73Defense mechanismsT2183.43Signal transduction mechanismsM1592.50Cell wall/membrane biogenesisN570.89Cell motilityU360.56Intracellular trafficking and secretionO1532.41Posttranslational modification, protein turnover, chaperonesC4477.03Energy production and conversionG2433.82Carbohydrate transport and metabolismE2984.69Amino acid transport and metabolismF821.29Nucleotide transport and metabolismH2103.30Coenzyme transport and metabolismI5588.78Lipid transport and metabolismP2393.76Inorganic ion transport and metabolismQ4947.77Secondary metabolites biosynthesis, transport and catabolismR79512.51General function prediction onlyS3585.63Function unknown--108217.03Not in COGs^a^The total is based on the total number of protein coding genes in the genomeFig. 2A graphical circular map of the [*M. simiae*](https://doi.org/10.1601/nm.6402) MsiGto genome keyed to the COGS functional categories. The circular map was generated using BASys web server \[[@CR61]\]

Insights from the genome sequence {#Sec10}
=================================

Extended insights {#Sec11}
-----------------

We report here the third genome sequence of [*M. simiae*](https://doi.org/10.1601/nm.6402). MsiGto was isolated from a clinical sample obtained from an elderly woman, and is the largest [*M. simiae*](https://doi.org/10.1601/nm.6402) genome reported to date with an approximate 745 Kbp additional to the next largest genome (strain MO323). As pathogenic mycobacteria tend to undergo genome decay \[[@CR28], [@CR29]\], the large genomic size of MsiGto speaks out of an organism capable of thriving in both environmental conditions and in the human host. Indeed, by comparison, the genome of [*M. tuberculosis*](https://doi.org/10.1601/nm.10886), an obligate pathogen, is significantly smaller with 4.41 Mb \[[@CR30]\]. Meanwhile, with 6406 genes, the genome size of MsiGto is similar to that of the opportunistic pathogen [*Pseudomona aeruginosa*](https://doi.org/10.1601/nm.2553) (5570 predicted ORFs), which thrives in a variety of environments including soil, water, as well as the multiple human tissues it infects \[[@CR31]\]. Analysis of the [*P. aeruginosa*](https://doi.org/10.1601/nm.2553) genome evidenced its large size arose from genetic expansion to enhance functional diversity rather than from gene duplication \[[@CR32]\]. Interestingly, investigating protein families in MsiGto, in comparison with MO323 and [DSM 44165](https://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+44165), evidenced a larger proportion of proteins uniquely found in MsiGto (1.17 times more than [DSM 44165](https://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+44165) and 4.7 times more than MO323), suggestive of a relatively increased versatility in accordance with the multiple niches it can thrive in (Fig. [3](#Fig3){ref-type="fig"}).Fig. 3Venn diagram analysis showing the number of unique and shared family proteins as evidenced using PATRIC, between the *M. simiae* strains MO323, DSM 44165 and MsiGto

The genome of MsiGto is rich in virulence factors, genes conferring infective mechanisms, and host immune response evasion systems. Some of these proteins are common to other pathogenic mycobacteria, and shared by the two previously sequenced [*M. simiae*](https://doi.org/10.1601/nm.6402) genomes, such as ESAT-6, known to modulate host immune responses by affecting human T-cell responses \[[@CR33], [@CR34]\]. Interestingly, all [*M. simiae*](https://doi.org/10.1601/nm.6402) strains including MsiGto have three of the four antigen 85 complex genes (*fbpA*, *fbpC*, and *fbpD*) responsible for cell wall synthesis. The enzyme products of these genes are responsible for the conversion of trehalose monomycolate (TMM) into the Cord Factor trehalose dimycolate (TDM) \[[@CR35]\], which is considered one of the most important virulence factors of mycobacteria \[[@CR36]\]. Other genera belonging to the [*Mycobacteriaceae*](https://doi.org/10.1601/nm.6309) family that include both pathogenic and environmental species, such as [*Rhodococcus*](https://doi.org/10.1601/nm.6471) \[[@CR37]\], [*Corynebacterium*](https://doi.org/10.1601/nm.6188) and [*Nocardia*](https://doi.org/10.1601/nm.6418) \[[@CR38]\], also produce TDM \[[@CR39]\].

Mammalian Cell Entry proteins are cell surface exposed proteins that play a crucial role in [*M. tuberculosis*](https://doi.org/10.1601/nm.10886) virulence by permitting the bacteria to enter mammalian cells and survive inside the macrophage, modulating the immune response \[[@CR40], [@CR41]\]. Mce clusters consist of 4 homologous operons in [*M. tuberculosis*](https://doi.org/10.1601/nm.10886) (*mce1*, *mce2*, *mce3*, *mce4*) with a similar arrangement: two genes encoding integral membrane proteins followed by six *mce* genes (A, B, C D, E and F) \[[@CR40]\]. Mce proteins are also involved in lipid metabolism, acting as transporters and allowing cholesterol degradation to free carbon and energy for use by [*M. tuberculosis*](https://doi.org/10.1601/nm.10886) \[[@CR41]\]. In the genome of MsiGto we found that the cluster *mce3* is overrepresented. While the [DSM 44165](https://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+44165) and MO323 genomes present none and a single copy of mce3, respectively, two complete copies of the *mce3* cluster were found in MsiGto. As the transition from an environmental organism to a pathogen has been associated with the acquisition of Mce genes in actinobacteria \[[@CR42]\], and Mce3 proteins are expressed by [*M. tuberculosis*](https://doi.org/10.1601/nm.10886) during the infection phase \[[@CR43]\], it is tempting to speculate the increased number of Mce3 copies found in MsiGto provided the strain with human infection potential.

The presence of multiple copies of these potential lipid transporters in mycobacterial genomes is consistent with the finding that pathogenic mycobacteria switch from carbohydrates to lipids as their main carbon and energy source inside cells \[[@CR44]\]. The evolution of this locus, through duplication and divergence, has almost certainly contributed to virulence in mycobacteria, and even in other distantly related actinobacteria, such as [*Streptomyces*](https://doi.org/10.1601/nm.6817) \[[@CR42], [@CR45]\]. Given that the ability to acquire cholesterol from the host is crucial to maintain a chronic infection, we postulate that cells having a large *mce* copy number, such as that found in MsiGto, may potentially evolve pathogenicity relatively faster when compared with other environmental mycobacteria.

A total of 493 protein families were found exclusively present in MsiGto when compared to the other two available [*M. simiae*](https://doi.org/10.1601/nm.6402) genomes (MO323 and [DSM 44165](https://doi.org/10.1601/strainfinder?urlappend=%3Fid%3DDSM+44165)). Consistent with findings in the [*Pseudomonas aeruginosa*](https://doi.org/10.1601/nm.2553) \[[@CR46]\] genome \[[@CR32]\], it seems that MsiGto has undergone genome expansion. Within the gene pool unique to MsiGto we found the arginine/ornithine antiporter gene *arcD*, which is involved in the persistence of the zoonotic pathogen [*Streptococcus suis*](https://doi.org/10.1601/nm.5688) \[[@CR47]\] in host cells \[[@CR48]\]. Additional unique genes found in the MsiGto genome participate in aromatic amino acid metabolic pathways. For instance, 2-oxo-hepta-3-ene-1,7-dioic acid hydratase (*hpcG* gene, EC 4.2.1.80) participates in the degradation of tyrosine and the 2-keto-3-deoxy-D-arabino-heptulosonate-7-phosphate synthase I alpha participates in the synthesis of chorismate (*aroG* gene, EC 2.5.1.54). The latter is an interesting observation as tyrosine is a key nutrient source during infectious growth within macrophages of some pathogenic fungus \[[@CR49], [@CR50]\]. [At this](http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?lvl=0&id=240702) stage, however, it would be risky to rule out the involvement of these specific genes in important environmental functions that allow MsiGto to survive outside the host, or during both lifestyles.

Conclusions {#Sec12}
===========

[*Mycobacterium simiae*](https://doi.org/10.1601/nm.6402) is an organism of interest for genomic studies due to the scarce genomic data available, and its recent emergence as a human pathogen. Here we present the largest genome sequence of this species to date. The genome of [*M. simiae*](https://doi.org/10.1601/nm.6402) MsiGto presents characteristics in accordance with its adaptation to infect the Human host, with the presence of numerous virulence genes, plus some specific features that deserve further investigation. Additional [*M. simiae*](https://doi.org/10.1601/nm.6402) genomes, from both environmental and clinical isolates, should be sequenced to provide a wider evolutionary picture with functional implications. Indeed, our comparative analysis helps to better understand the evolution of host-pathogen interactions, and the molecular mechanisms of virulence, of this emergent human pathogen.
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